SG10201810284VA - Anti-pd1 antibodies and their use as therapeutics and diagnostics - Google Patents

Anti-pd1 antibodies and their use as therapeutics and diagnostics

Info

Publication number
SG10201810284VA
SG10201810284VA SG10201810284VA SG10201810284VA SG10201810284VA SG 10201810284V A SG10201810284V A SG 10201810284VA SG 10201810284V A SG10201810284V A SG 10201810284VA SG 10201810284V A SG10201810284V A SG 10201810284VA SG 10201810284V A SG10201810284V A SG 10201810284VA
Authority
SG
Singapore
Prior art keywords
antibodies
therapeutics
diagnostics
binding
mediated
Prior art date
Application number
SG10201810284VA
Inventor
Jing Song
Kang Li
Tong Zhang
Lanlan Xu
Qi Liu
Hao Peng
Original Assignee
Beigene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beigene Ltd filed Critical Beigene Ltd
Priority to SG10201810284VA priority Critical patent/SG10201810284VA/en
Publication of SG10201810284VA publication Critical patent/SG10201810284VA/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

ANTI-PD1 ANTmODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS Provided are antibodies that specifically bind to Programmed Death-I (PD I, Pdcd-I, or CD279) and inhibit PD I-mediated cellular signaling and activities in immune cells, antibodies binding to a set of amino acid residues required for its ligand binding, and uses of these antibodies to treat or diagnose cancer, infectious diseases or other pathological disorders modulated by PDI- mediated functions. Figure for publication: None
SG10201810284VA 2013-09-13 2013-09-13 Anti-pd1 antibodies and their use as therapeutics and diagnostics SG10201810284VA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG10201810284VA SG10201810284VA (en) 2013-09-13 2013-09-13 Anti-pd1 antibodies and their use as therapeutics and diagnostics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201810284VA SG10201810284VA (en) 2013-09-13 2013-09-13 Anti-pd1 antibodies and their use as therapeutics and diagnostics

Publications (1)

Publication Number Publication Date
SG10201810284VA true SG10201810284VA (en) 2018-12-28

Family

ID=65011678

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201810284VA SG10201810284VA (en) 2013-09-13 2013-09-13 Anti-pd1 antibodies and their use as therapeutics and diagnostics

Country Status (1)

Country Link
SG (1) SG10201810284VA (en)

Similar Documents

Publication Publication Date Title
NZ718643A (en) Anti-pd1 antibodies and their use as therapeutics and diagnostics
MX2020006896A (en) Anti-tigit antibodies and their use as therapeutics and diagnostics.
PH12018500394A1 (en) Pd-l1 ("programmed death-ligand 1") antibodies
MX2020004503A (en) Humanized or chimeric cd3 antibodies.
MX347164B (en) Anti il-36r antibodies.
PH12014502406A1 (en) Anti-il-23p19 antibodies
PH12015502293A1 (en) Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use
MX2021007663A (en) Target-tissue-specific antigen-binding molecule.
MX369220B (en) Cd3-binding molecules capable of binding to human and non-human cd3.
MX343858B (en) Anti-il-23 antibodies.
MX2015016111A (en) Anti-b7-h5 antibodies and their uses.
EA201590671A1 (en) COMBINATION OF ANTIBODIES TO KIR AND ANTIBODIES TO PD-1 FOR THE TREATMENT OF MALIGNANT TUMOR
UA117565C2 (en) Novel rig-i ligands and methods for producing them
MX343659B (en) Fc RECEPTOR BINDING PROTEINS.
EA201390128A1 (en) PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS
WO2014106001A3 (en) Dual specific binding proteins having a receptor sequence
MX358683B (en) Potato protein isolates.
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
NZ630864A (en) Use of semaphorin-4d binding molecules to promote neurogenesis following stroke
EA201590237A1 (en) NEW METHODS OF ANTIBODY TREATMENT AGAINST HER2 WITH LOW FUZOZYLATION
TN2017000451A1 (en) Igf-1r antibody and its use for the diagnosis of cancer
SG10201810284VA (en) Anti-pd1 antibodies and their use as therapeutics and diagnostics
SA517390221B1 (en) IGF-1R Antibody and its Use for The Diagnosis of Cancer
TW201613863A (en) Process for the preparation of 4,5,6-trichloropicolinic acid
EA201992798A3 (en) ANTIBODIES AGAINST PD1 AND THEIR APPLICATION AS A THERAPEUTIC AND DIAGNOSTIC MEANS